0001209191-11-031209.txt : 20110526
0001209191-11-031209.hdr.sgml : 20110526
20110526155513
ACCESSION NUMBER: 0001209191-11-031209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110525
FILED AS OF DATE: 20110526
DATE AS OF CHANGE: 20110526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Emmens Matthew
CENTRAL INDEX KEY: 0001298332
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 11874042
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST., ATTN: GENERAL COUNSEL
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-05-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001298332
Emmens Matthew
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
CEO & President
Common Stock
2011-05-25
4
S
0
9735
55.51
D
220400
D
Open market sales reported on this line occurred at a weighted average price of $55.51 (range $55.27 to $55.66).
Mr. Emmens undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Kenneth S. Boger, Attorney-In-Fact
2011-05-26